Allogeneic stem cell transplantation for chronic myeloid leukaemia is safe and effective in high risk patients following second generation tyrosine kinase inhibitors: A single centre's experience.

Latif, Anne-Louise; McQuaker, Grant; Parker, Anne; Clark, Andrew; Copland, Mhairi

Latif, Anne-Louise; McQuaker, Grant; Parker, Anne; Clark, Andrew; Copland, Mhairi.

Afiliação

Latif AL; Beatson Institute for Cancer Research, Switchback Road, Bearsden, Glasgow, G61 1BD, UK.
McQuaker G; Bone Marrow Transplant Unit, Beatson West of Scotland Cancer Centre, 1053 Great Western Road, Glasgow, G12 OYN, UK.
Parker A; Bone Marrow Transplant Unit, Beatson West of Scotland Cancer Centre, 1053 Great Western Road, Glasgow, G12 OYN, UK.
Clark A; Bone Marrow Transplant Unit, Beatson West of Scotland Cancer Centre, 1053 Great Western Road, Glasgow, G12 OYN, UK.
Copland M; Bone Marrow Transplant Unit, Beatson West of Scotland Cancer Centre, 1053 Great Western Road, Glasgow, G12 OYN, UK ; Paul O'Gorman Leukaemia Research Centre, College of Medical, Veterinary and Life Sciences, Institute of Cancer Sciences, University of Glasgow, 21 Shelley Road, Gartnavel General Hosp

Leuk Res Rep ; 2(2): 47-50, 2013.

Article em En | MEDLINE | ID: mdl-24371779

Palavras-chave

Chronic myeloid leukaemia (CML); Haematopoietic stem cell transplant (HSCT); Tyrosine kinase inhibitor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: Leuk Res Rep Ano de publicação: 2013 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google